CSIMarket
 


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 

Organicell Regenerative Medicine Inc 's Working Capital Ratio

BPSR's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




BPSR Working Capital Ratio (Jul 31 2021)
III. Quarter
(Apr 30 2021)
II. Quarter
(Jan 31 2021)
I. Quarter
(Oct 31 2020)
IV. Quarter
(Jul 31 2020)
III. Quarter
Y / Y Current Liabilities Change 40.03 % 42.54 % 34.69 % 24.75 % 68.98 %
Y / Y Current Assets Change 30.95 % 20.36 % -9.46 % 137.94 % 199.52 %
Working Capital Ratio MRQ 0.21 0.17 0.1 0.34 0.23
Overall Ranking # # # # #
Seq. Current Liabilities Change 11.22 % -1.43 % 41.13 % -9.49 % 13.21 %
Seq. Current Assets Change 38.52 % 60.29 % -56.51 % 35.6 % 27.31 %



Working Capital Ratio third quarter 2021 Comment
Organicell Regenerative Medicine Inc 's Current Assets grew by 38.52 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Organicell Regenerative Medicine Inc 's Working Capital Ratio to 0.21, Working Capital Ratio remained below Organicell Regenerative Medicine Inc average.

Within Biotechnology & Pharmaceuticals industry 226 other companies have achieved higher Working Capital Ratio than Organicell Regenerative Medicine Inc in third quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is BPSR most successful ?
Working Capital Ratio BPSR on the trailing twelve month basis
Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 227
Healthcare Sector # 924
Overall Market # 5030


Working Capital Ratio Statistics
High Average Low
2.76 0.34 0.03
(Jul 31 2013)   (Jul 31 2016)




Financial Statements
Organicell Regenerative Medicine Inc 's Current Liabilities $ 4 Millions Visit BPSR's Balance sheet
Organicell Regenerative Medicine Inc 's Current Assets $ 1 Millions Visit BPSR's Balance sheet
Source of BPSR's Sales Visit BPSR's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJul 31 2021, within Biotechnology & Pharmaceuticals Industry Working Capital RatioJul 31 2021 MRQ Current AssetsJul 31 2021 MRQ Current Liabilities
Agenus Inc  0.55 $ 92.854  Millions$ 168.754  Millions
Petvivo Holdings Inc   0.42 $ 0.559  Millions$ 1.341  Millions
Ainos Inc  0.37 $ 0.869  Millions$ 2.376  Millions
American Bio Medica Corporation  0.31 $ 0.953  Millions$ 3.107  Millions
Axim Biotechnologies Inc   0.30 $ 0.412  Millions$ 1.364  Millions
Inhibitor Therapeutics Inc   0.30 $ 0.127  Millions$ 0.420  Millions
Guided Therapeutics Inc  0.29 $ 1.640  Millions$ 5.671  Millions
Gtx Corp  0.26 $ 0.781  Millions$ 2.994  Millions
Theralink Technologies Inc   0.26 $ 0.766  Millions$ 3.001  Millions
Nascent Biotech Inc  0.25 $ 0.276  Millions$ 1.110  Millions
Organicell Regenerative Medicine Inc   0.21 $ 0.834  Millions$ 3.929  Millions
Cure Pharmaceutical Holding Corp  0.19 $ 3.290  Millions$ 17.039  Millions
Twinlab Consolidated Holdings Inc   0.18 $ 24.844  Millions$ 139.016  Millions
Therapeutic Solutions International Inc  0.15 $ 0.317  Millions$ 2.066  Millions
Q Biomed Inc   0.14 $ 0.410  Millions$ 2.977  Millions
Creative Medical Technology Holdings Inc  0.11 $ 0.159  Millions$ 1.447  Millions
Cell Medx Corp   0.11 $ 0.051  Millions$ 0.467  Millions
Qrons Inc   0.09 $ 0.088  Millions$ 0.977  Millions
Quest Patent Research Corporation  0.07 $ 0.834  Millions$ 11.615  Millions
Sangui Biotech International Inc  0.07 $ 0.067  Millions$ 0.955  Millions
Mymetics Corporation  0.05 $ 0.359  Millions$ 7.582  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SRSA's Profile

Stock Price

SRSA's Financials

Business Description

Fundamentals

Charts & Quotes

SRSA's News

Suppliers

SRSA's Competitors

Customers & Markets

Economic Indicators

SRSA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071